Join the Diabetes, Type 1 group to help and get support from people like you.
Diabetes, Type 1 News (Page 2)
Related terms: Insulin Dependent Diabetes, Juvenile onset diabetes, Type 1 Diabetes, Type One, Type 1, Type 1 Diabetes Mellitus
1990 to 2021 Saw Increase in Global Burden of Diabetic Nephropathy
MONDAY, March 17, 2025 – The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050, according to a study published online Feb. 21 in...
Glucose Monitors Improve Traffic Safety For Diabetic Drivers
TUESDAY, March 18, 2025 – Continuous glucose monitors don’t just help people with diabetes maintain healthy blood sugar levels, a new study says – the devices also can help them be safer drivers. D...
GLP-1 RA Use Tied to Better Kidney Transplant Outcomes in Patients With Diabetes
TUESDAY, March 18, 2025 – Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with better graft and patient survival among kidney transplant recipients with diabetes, according to...
Makers Drag Feet Reporting Medical Device Side Effects: Study
TUESDAY, March 18, 2025 – Other people could be having problems with the same insulin pump, dental implant or glucose monitor that you use – and you might not find out in a timely manner. That’s b...
1 in 3 Children Now Suffer From Chronic Illness
MONDAY, March 17, 2025 – Nearly 1 in 3 children live with a chronic condition that could significantly affect their health for the rest of their lives, a new study says. Chronic illnesses affected...
Turning Off TV Better For Heart Health Of Folks Predisposed To Diabetes
THURSDAY, March 13, 2025 – People with a higher genetic risk for type 2 diabetes also have a higher risk of heart attack, stroke and other heart-related diseases. But controlling that risk could be...
Recent Decade Saw No Change in Diabetes Prevalence in U.S. Adults
FRIDAY, March 7, 2025 – Between 2013 and 2023, there was no change in the prevalence of diabetes among U.S. adults, but glycemic control worsened, according to a research letter published online...
Study Explores Effect of Hybrid Closed-Loop Therapy on Diabetic Complications
FRIDAY, Feb. 28, 2025 – For young people with type 1 diabetes, hybrid closed-loop insulin delivery does not affect the rate of severe hypoglycemia and is associated with an increased risk for...
Probability of Cardiovascular Events Lower in Type 1 Diabetes Versus Type 2
TUESDAY, Feb. 25, 2025 – Diabetes mellitus type 1 (DM1) is associated with lower probability of incident cardiovascular events than type 2 (DM2), according to a study published online Feb. 12 in the...
FDA Approves Merilog (insulin-aspart-szjj), a Biosimilar to NovoLog
February 14, 2025 – Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to NovoLog (insulin aspart) for the improvement of glycemic control in adults...
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 – The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with...
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 – The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with...
Wrong Smartphone Settings Can Lead to Missed Alerts From Linked Diabetes Devices
TUESDAY, Feb. 11, 2025 – The U.S. Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are...
Body Weight Cycling Tied to Increased Risk for Renal Events in Type 1 Diabetes
MONDAY, Feb. 10, 2025 – For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an increased risk for renal events, according to a...
FDA Approves Susvimo for Diabetic Macular Edema
WEDNESDAY, Feb. 5, 2025 -- The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema. Susvimo is the first and only FDA-approved treatment ...
Further information
Related condition support groups
Related drug support groups
Lantus, Lantus Solostar, Humalog, Novolog, insulin glargine, insulin lispro, Tresiba, Levemir, insulin degludec, Humulin N